Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Urocit ®-K (Potassium Citrate) Extended Release Tablets for Oral Use These highlights do not include all the information needed to use Urocit ®-K safely and effectively. See full prescribing information for Urocit ®-K. Initial U.S. Approval: 1985
Medication labelWhy this: Advisory · dailymed-prescription
1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2)]. 1.3 Uric Acid Lithiasis with or without Calcium Stones Potassium citrate is indicated for the management of Uric acid lithiasis with or without calcium stones [see Clinical Studies (14.3)].
- generic_name
- potassium citrate
- product_names
- potassium citrate
- ndc
- 0178-0610, 0178-0600, 0178-0615, 0178-0610-01, 0178-0600-01, 0178-0615-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en